infusion-therapy
(3)
Baxter International Inc.
Baxter rarely gets the bedside spotlight. Its pumps, beds, monitors, medicines and IV bags are the practical infrastructure that lets modern care move - and the century-old company is rebuilding itself around a more connected hospital.
Tyler Payne
Tyler Payne is the founder and CEO of Vellum Health, an Austin-based company that sends clinicians to draw a line, hang an infusion, or run a blood transfusion at a patient's bedside in a skilled nursing facility or living room instead of an emergency room. He rolled up a set of regional vascular-access businesses, wrapped them in a single brand and an AI platform that reads a facility's EMR to find patients who need care, and closed a Series A in mid-2025 led by FCA Venture Partners. Before Vellum he helped build CVS Health's nationwide clinical-trial infrastructure and worked at Elligo Health Research and ePatientFinder. He holds a molecular biology degree from Colorado and an MBA from UT Austin's McCombs School.
Mike Asselta
Mike Asselta is the chief executive officer of Compassus, one of the largest home-based care companies in the United States, spanning home health, hospice, palliative care and infusion therapy across some 200 locations. Appointed in May 2024, he came from nearly eight years at Fresenius Medical Care North America, where he ran U.S. care delivery and Fresenius Kidney Care - an operation of more than 60,000 employees and 4,000 sites. At Compassus he has bet the company's growth on joint ventures with major health systems like Providence and OhioHealth, arguing that the future of care happens where people actually live: at home.